Optimal Transport Media for Maintaining Functional Mesenchymal Stem Cells during Hypothermic Preservation: A Systematic Review

Authors

  • Rona Kartika StemCells Medical Technology Installation, Cipto Mangunkusumo Hospital Jakarta, Indonesia
  • Niken Rahmah Ghanny Faculty of Medicine, Universitas Pembangunan Nasional ‘Veteran’ Jakarta
  • Maya Ulfah Faculty of Medicine, Universitas Lampung

DOI:

https://doi.org/10.59278/cbs.v5i14.109

Keywords:

human mesenchymal stem cells, storage, hypothermic preservation, transport medium

Abstract

Background: Human mesenchymal stem cells (hMSCs) are a promising and cost-effective therapeutic platform in regenerative medicine. However, their clinical application depends on maintaining cell viability and function during storage and transportation, as hMSCs are highly sensitive to pH imbalance, inappropriate medium composition, and temperature fluctuations. This systematic review aimed to identify the optimal hypothermic storage and transport media for hMSC-based therapies. Methods: This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was conducted in PubMed, The Cochrane Library, and ScienceDirect for studies published up to September 2025 within the previous 20 years. Search terms included mesenchymal stem cells, transport or preservation media, and hypothermic storage. A total of 1,076 records were identified. After removing duplicates and ineligible studies, 340 titles and abstracts were screened, and 21 studies were included in the qualitative synthesis. Results: The optimal storage or transport medium depended on the intended storage duration while preserving hMSC viability, phenotype, differentiation potential, and immunomodulatory function. Crystalloid solutions and conditioned medium were suitable for short-term storage (≤24 hours). Colloid solutions provided better preservation for up to 3 days, whereas specialized preservation solutions were most effective for storage up to 7 days. For prolonged storage (>7 days), supplementation with trehalose and antioxidants showed potential to improve cell preservation, although supporting evidence remains limited. Conclusions: Selection of the hypothermic storage medium should be guided by the anticipated storage duration to maximize hMSC quality and functionality and support the clinical translation of hMSC-based therapies.

References

1. Zhu C, Wu W, Qu X. Mesenchymal stem cells in osteoarthritis therapy: a review. Am J Transl Res. 2021;13(2):448-61.

2. Cao M, Ou Z, Sheng R, Wang Q, Chen X, Zhang C, et al. Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Research & Therapy. 2025;16(1):122.

3. Shin TH, Kim HS, Choi SW, Kang KS. Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action. Int J Mol Sci. 2017;18(2).

4. Calle Sdl, Zurita M. Mesenchymal stem cell for hemorrhagic stroke: A clinical review. Regenerative Therapy. 2025;30:173-81.

5. Jingli Y, Jing W, Saeed Y. Ischemic Brain Stroke and Mesenchymal Stem Cells: An Overview of Molecular Mechanisms and Therapeutic Potential. Stem Cells Int. 2022;2022:5930244.

6. Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduction and Targeted Therapy. 2022;7(1):92.

7. Vizoso FJ, Eiro N, Costa L, Esparza P, Landin M, Diaz-Rodriguez P, et al. Mesenchymal Stem Cells in Homeostasis and Systemic Diseases: Hypothesis, Evidences, and Therapeutic Opportunities. Int J Mol Sci. 2019;20(15).

8. Bahari M, Mokhtari H, Yeganeh F. Stem Cell Therapy, the Market, the Opportunities and the Threat. Int J Mol Cell Med. 2023;12(3):310-9.

9. Giancola R, Bonfini T, Iacone A. Cell therapy: cGMP facilities and manufacturing. Muscles Ligaments Tendons J. 2012;2(3):243-7.

10. Lipsitz YY, Milligan WD, Fitzpatrick I, Stalmeijer E, Farid SS, Tan KY, et al. A roadmap for cost-of-goods planning to guide economic production of cell therapy products. Cytotherapy. 2017;19(12):1383-91.

11. Sohn HS, Heo JS, Kim H-S, Choi Y, Kim HO. Duration of in vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation. Cytotherapy. 2013;15(4):460-6.

12. Guadix JA, López-Beas J, Clares B, Soriano-Ruiz JL, Zugaza JL, Gálvez-Martín P. Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges. Pharmaceutics. 2019;11(11).

13. Ma Y, Gao L, Tian Y, Chen P, Yang J, Zhang L. Advanced biomaterials in cell preservation: Hypothermic preservation and cryopreservation. Acta Biomaterialia. 2021;131:97-116.

14. Buskirk RGV, Baust JM, Snyder KK, Mathew AJ, Baust JG, editors. Hypothermic Storage and Cryopreservation Successful Short-and Long-Term Preservation of Cells and Tissues2004.

15. Tam E, McGrath M, Sladkova M, AlManaie A, Alostaad A, de Peppo GM. Hypothermic and cryogenic preservation of tissue-engineered human bone. Ann N Y Acad Sci. 2020;1460(1):77-87.

16. Freitas-Ribeiro S, Reis RL, Pirraco RP. Long-term and short-term preservation strategies for tissue engineering and regenerative medicine products: state of the art and emerging trends. PNAS Nexus. 2022;1(4).

17. Farma K. STEM CELL PRODUCTION FACILITY SUCCESSFULLY OBTAINS GMP CERTIFICATE 2024 [Available from: https://www.kimiafarma.co.id/en/read/stem-cell-production-facility-successfully-obtains-gmp-certificate.

18. Eden J, Levit L, Berg A, Morton S. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Checklist. Finding What Works in Health Care: Standards for Systematic Reviews: National Academies Press (US); 2011.

19. Yen BL, Liu K-J, Sytwu H-K, Yen M-L. Clinical implications of differential functional capacity between tissue-specific human mesenchymal stromal/stem cells. The FEBS Journal. 2023;290(11):2833-44.

20. Ngo ATL, Le HM, Trinh NTH, Jun APG, Bach TQ, Bui HTH, et al. Clinically relevant preservation conditions for mesenchymal stem/stromal cells derived from perinatal and adult tissue sources. J Cell Mol Med. 2021;25(22):10747-60.

21. Petrenko Y, Chudickova M, Vackova I, Groh T, Kosnarova E, Cejkova J, et al. Clinically Relevant Solution for the Hypothermic Storage and Transportation of Human Multipotent Mesenchymal Stromal Cells. Stem Cells Int. 2019;2019:5909524.

22. Corwin WL, Baust JM, Baust JG, Van Buskirk RG. Characterization and modulation of human mesenchymal stem cell stress pathway response following hypothermic storage. Cryobiology. 2014;68(2):215-26.

23. Swioklo S, Constantinescu A, Connon CJ. Alginate-Encapsulation for the Improved Hypothermic Preservation of Human Adipose-Derived Stem Cells. Stem Cells Transl Med. 2016;5(3):339-49.

24. Gálvez-Martín P, Hmadcha A, Soria B, Calpena-Campmany AC, Clares-Naveros B. Study of the stability of packaging and storage conditions of human mesenchymal stem cell for intra-arterial clinical application in patient with critical limb ischemia. Eur J Pharm Biopharm. 2014;86(3):459-68.

25. Chen Y, Yu B, Xue G, Zhao J, Li RK, Liu Z, et al. Effects of storage solutions on the viability of human umbilical cord mesenchymal stem cells for transplantation. Cell Transplant. 2013;22(6):1075-86.

26. Abazari A, Hawkins B, Clarke D, Mathew A. Biopreservation best practices: a cornerstone in the supply chain of cell-based therapies–MSC model case study. Cell and Gene Therapy Insights. 2018.

27. Celikkan FT, Mungan C, Sucu M, Ulus AT, Cinar O, Ili EG, et al. Optimizing the transport and storage conditions of current Good Manufacturing Practice –grade human umbilical cord mesenchymal stromal cells for transplantation (HUC-HEART Trial). Cytotherapy. 2019;21(1):64-75.

28. Muraki K, Hirose M, Kotobuki N, Kato Y, Machida H, Takakura Y, et al. Assessment of viability and osteogenic ability of human mesenchymal stem cells after being stored in suspension for clinical transplantation. Tissue Eng. 2006;12(6):1711-9.

29. Di G, Wang J, Liu M, Wu CT, Han Y, Duan H. Development and evaluation of a trehalose-contained solution formula to preserve hUC-MSCs at 4°C. J Cell Physiol. 2012;227(3):879-84.

30. Sohn HS, Heo JS, Kim HS, Choi Y, Kim HO. Duration of in vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation. Cytotherapy. 2013;15(4):460-6.

31. Ścieżyńska A, Soszyńska M, Szpak P, Krześniak N, Malejczyk J, Kalaszczyńska I. Influence of Hypothermic Storage Fluids on Mesenchymal Stem Cell Stability: A Comprehensive Review and Personal Experience. Cells. 2021;10(5).

32. Wicaksono H, Prasetio A, Irawan RCS, Arifin NA. Effect of Time Transport on Mesenchymal Stem Cell Surface Markers: Unveiling the Influence of Cellular Translocation on Cellular Phenotype. International Journal of Cell and Biomedical Science. 2023;2(4):134-8.

33. Yu NH, Chun SY, Ha YS, Kim HT, Kim DH, Kim J, et al. Optimal Stem Cell Transporting Conditions to Maintain Cell Viability and Characteristics. Tissue Eng Regen Med. 2018;15(5):639-47.

34. Wada T, Takenawa T, Komori N, Nishimura M, Fujita Y, Sawamoto O. Ascorbic acid enhances the cold preservation period of human adipose tissue-derived mesenchymal stromal cells. Regen Ther. 2023;24:154-60.

35. Veronesi E, Murgia A, Caselli A, Grisendi G, Piccinno MS, Rasini V, et al. Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration. Tissue Eng Part C Methods. 2014;20(3):239-51.

36. Pal R, Hanwate M, Totey SM. Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation. J Tissue Eng Regen Med. 2008;2(7):436-44.

37. Hajmousa G, Vogelaar P, Brouwer LA, van der Graaf AC, Henning RH, Krenning G. The 6-chromanol derivate SUL-109 enables prolonged hypothermic storage of adipose tissue-derived stem cells. Biomaterials. 2017;119:43-52.

38. Branco A, Tiago AL, Laranjeira P, Carreira MC, Milhano JC, Dos Santos F, et al. Hypothermic Preservation of Adipose-Derived Mesenchymal Stromal Cells as a Viable Solution for the Storage and Distribution of Cell Therapy Products. Bioengineering (Basel). 2022;9(12).

39. Freitas-Ribeiro S, Carvalho AF, Costa M, Cerqueira MT, Marques AP, Reis RL, et al. Strategies for the hypothermic preservation of cell sheets of human adipose stem cells. PLoS One. 2019;14(10):e0222597.

40. Wang P, Ye L, Si S. Quercetin enhances the cold storage effect on human umbilical cord mesenchymal stem cells in Celsior solution. Cryobiology. 2025;120:105299.

41. Ostrowska A, Gu K, Bode DC, Van Buskirk RG. Hypothermic storage of isolated human hepatocytes: a comparison between University of Wisconsin solution and a hypothermosol platform. Archives of Toxicology. 2009;83(5):493-502.

42. Remadi J-P, Baron O, Roussel JC, Al Habash O, Treilhaud M, Despins P, et al. Myocardial preservation using Celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations. The Annals of thoracic surgery. 2002;73(5):1495-9.

43. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7.

44. Nguyen T, Ha T, Do V, Nguyen T, Le T, Nguyen T, et al. Hypothermic storage of Vietnamese stem cells from exfoliated deciduous teeth using crystalloid electrolyte solutions. Vietnam Journal of Biotechnology. 2025;23:137-57.

45. Rudloff E, Hopper K. Crystalloid and Colloid Compositions and Their Impact. Front Vet Sci. 2021;8:639848.

46. Izaguirre-Pérez N, Ligero G, Aguilar-Solana PA, Carrillo-Ávila JA, Rodriguez-Reyes CR, Biunno I, et al. Trehalose Cryopreservation of Human Mesenchymal Stem Cells from Cord Tissue. Biopreserv Biobank. 2025;23(4):374-82.

47. Pinilla-González V, Rojas-Solé C, Gómez-Hevia F, González-Fernández T, Cereceda-Cornejo A, Chichiarelli S, et al. Tapping into Nature’s Arsenal: Harnessing the Potential of Natural Antioxidants for Human Health and Disease Prevention. Foods. 2024;13(13):1999.

48. Mattar P, Bieback K. Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells. Frontiers in Immunology. 2015;Volume 6 - 2015.

49. Ouzin M, Kogler G. Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications. Cells. 2023;12(16):2039.

50. Česnik AB, Švajger U. The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review. Frontiers in Cell and Developmental Biology. 2024;Volume 12 - 2024.

51. Vackova I, Vavrinova E, Musilkova J, Havlas V, Petrenko Y. Hypothermic Storage of 3D Cultured Multipotent Mesenchymal Stromal Cells for Regenerative Medicine Applications. Polymers. 2022;14(13):2553.

52. Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JA. Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects. Cryobiology. 2015;71(2):181-97.

Downloads

Published

2026-10-31

Issue

Section

Review Articles

How to Cite

Optimal Transport Media for Maintaining Functional Mesenchymal Stem Cells during Hypothermic Preservation: A Systematic Review. (2026). International Journal of Cell and Biomedical Science, 5(14), 533-557. https://doi.org/10.59278/cbs.v5i14.109